drugset / Trial / NCT06634069

Study SOLACE SEPSIS

NCT06634069

Phase 2 Recruiting 40 enrolled University Hospital Pilsen
RandomizedParallel-groupDouble-blindTreatment

Summary

A Pilot, Randomized, Double-Blinded, Controlled Study of Hemodynamic and Acid Base Effects of 0.5M Sodium Lactate and 3% Saline Solutions in Septic Shock Patients

Timeline

Start
2024-11-24
Primary completion
2027-10-31
Completion
2027-10-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator 3% NaCl Unknown 3 %
Subject Sodium Lactate Other / unclassified 0.5 unknown